Clinical Trials Browser

Phase 1 × INDUSTRY × avasopasem manganese × Clear all

NCT01921426 2016-09-22

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Stomatitis